Conmed (CNMD) Tops Q2 EPS by 9c, Offers Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $35.11 --0%
EPS Growth %: -3.5%
Financial Fact:
Income before income taxes: 9.99M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -3.5%
Financial Fact:
Income before income taxes: 9.99M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q2 EPS of $0.71, $0.09 better than the analyst estimate of $0.62. Revenue for the quarter came in at $255.2 million versus the consensus estimate of $248.31 million.
GUIDANCE:
Conmed sees FY2021 EPS of $3.15-$3.25, versus the consensus of $3.15. Conmed sees FY2021 revenue of $1.02-1.04 billion, versus the consensus of $1.02 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- RxSight cuts 2026 sales outlook, citing competitive headwinds
- JPMorgan Starts Zensho Holdings (7550:JP) at Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
